| Literature DB >> 34932003 |
Caterina Bérubé1, Zsolt Ferenc Kovacs1, Elgar Fleisch1,2,3, Tobias Kowatsch1,2,3.
Abstract
BACKGROUND: Noncommunicable diseases (NCDs) constitute a burden on public health. These are best controlled through self-management practices, such as self-information. Fostering patients' access to health-related information through efficient and accessible channels, such as commercial voice assistants (VAs), may support the patients' ability to make health-related decisions and manage their chronic conditions.Entities:
Keywords: agent; assistant; audio; conversational agents; evaluation; factorial; health information; health literacy; information source; literacy; management; mobile phone; noncommunicable diseases; protocol; smart display; smart speaker; voice assistants
Mesh:
Year: 2021 PMID: 34932003 PMCID: PMC8726026 DOI: 10.2196/32161
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Description of source types with examples.
| Source type | Description | Examples |
| Expert | Site from a health organization representing a group of medical professionals, a governmental medical department or agency, a nonprofit medical organization, or a medical journal. These are considered reliable because they consistently provide verified and impartial information. | US Centers for Disease Control and Prevention (CDC), Mayo Clinic, |
| Commercial | Any not nonprofit site that publishes medical information. These may or may not provide verified and impartial information. | WebMD, Medscape |
| Crowdsourced | Information from a site that is based on the collaboration of a large group of people. This information may or may not be verified and impartial. | Wikipedia, Blurtit |
| Not stated | The source type was not stated explicitly. | —a |
aNot available.
Number of questions before validation from medical specialists.
| NCDa | Questions generated (N=607), n (%) |
| ADb | 48 (7.9) |
| LCAc | 145 (23.9) |
| COPDd | 60 (9.9) |
| DMe | 135 (22.2) |
| CVDf | 93 (15.3) |
| CKDg | 69 (11.4) |
| CVAh | 57 (9.4) |
aNCD: noncommunicable disease.
bAD: Alzheimer’s disease.
cLCA: lung cancer.
dCOPD: chronic obstructive pulmonary disease.
eDM: diabetes mellitus.
fCVD: cardiovascular disease.
gCKD: chronic kidney disease.
hCVA: cerebrovascular accident.
Operationalization of the independent variables.
| Modality | Amazon | Apple | |
| Voice only | Smart speaker (Eco Dot) | Smart speaker (HomePod Mini) | Smart speaker (Nest Mini) |
| Voice and display | Smart display (Eco Show) | Smartphone (iPhone 8, iOS 14.4) | Smartphone (Nokia 6.1, Android 9) |
| Display only | —a | — | Laptop (Lenovo ThinkPad X1 Carbon Gen 6, |
aNot available.
Response rate across developers and modalities.
| Response | Display only (N=60), n (%) | Voice and display (N=180), n (%) | Voice only (N=180), n (%) | Total (N=420), n (%) | |
|
| |||||
|
| No | —a | 14 (23.3) | 15 (25) | 29 (24.2) |
|
| Yes | — | 46 (76.7) | 45 (75) | 91 (75.8) |
|
| Total | — | 60 (100) | 60 (100) | 120 (100) |
|
| |||||
|
| No | — | 48 (80) | 47 (78.3) | 95 (79.2) |
|
| Yes | — | 12 (20) | 13 (21.7) | 25 (20.8) |
|
| Total | — | 60 (100) | 60 (100) | 120 (100) |
|
| |||||
|
| No | — | 6 (10) | 0 | 6 (5) |
|
| Yes | — | 54 (90) | 60 (100) | 114 (95) |
|
| Total | — | 60 (100) | 60 (100) | 120 (100) |
|
| |||||
|
| No | 12 (20) | — | — | 12 (20) |
|
| Yes | 48 (80) | — | — | 48 (80) |
|
| Total | 60 (100) | — | — | 60 (100) |
aNot available.
Source type across developers and modalities.
| Source type | Display only (N=48), | Voice and display (N=112), | Voice only (N=118), | Total (N=278), | |||
|
| |||||||
|
| Commercial | —a | 11 (23.9) | 9 (20) | 20 (22) | ||
|
| Crowdsourced | — | 4 (8.7) | 4 (8.9) | 8 (8.8) | ||
|
| Expert | — | 27 (58.7) | 28 (62.2) | 55 (60.4) | ||
|
| Not stated | — | 4 (8.7) | 4 (8.9) | 8 (8.8) | ||
|
| Total | — | 46 (100) | 45 (100) | 91 (100) | ||
|
| |||||||
|
| Commercial | — | 2 (16.7) | 2 (15.4) | 4 (16) | ||
|
| Crowdsourced | — | 6 (50) | 3 (23.1) | 9 (36) | ||
|
| Expert | — | 1 (8.3) | 1 (7.7) | 2 (8) | ||
|
| Not stated | — | 3 (25) | 7 (53.8) | 10 (40) | ||
|
| Total | — | 12 (100) | 13 (100) | 25 (100) | ||
|
| |||||||
|
| Commercial | — | 12 (22.2) | 12 (20) | 24 (21.1) | ||
|
| Crowdsourced | — | 3 (5.6) | 3 (5) | 6 (5.3) | ||
|
| Expert | — | 39 (72.2) | 45 (75) | 84 (73.7) | ||
|
| Total | — | 54 (100) | 60 (100) | 114 (100) | ||
|
| |||||||
|
| Commercial | 15 (31.3) | — | — | 15 (31.3) | ||
|
| Expert | 33 (68.8) | — | — | 33 (68.8) | ||
|
| Total | 48 (100) | — | — | 48 (100) | ||
aNot available.
Response rate by developer and disease.
| Response | LCAa (N=70), | COPDb | DMc (N=70), | CVDd (N=70), | CKDe (N=70), | CVAf (N=70), | Total (N=420), | |
|
| ||||||||
|
| No | —g | 8 (40) | 2 (10) | 6 (30) | 7 (35) | 6 (30) | 29 (24.2) |
|
| Yes | 20 (100) | 12 (60) | 18 (90) | 14 (70) | 13 (65) | 14 (70) | 91 (75.8) |
|
| Total | 20 (100) | 20 (100) | 20 (100) | 20 (100) | 20 (100) | 20 (100) | 120 (100) |
|
| ||||||||
|
| No | 8 (40) | 16 (80) | 19 (95) | 18 (90) | 18 (90) | 16 (80) | 95 (79.2) |
|
| Yes | 12 (60) | 4 (20) | 1 (5) | 2 (10) | 2 (10) | 4 (20) | 25 (20.8) |
|
| Total | 20 (100) | 20 (100) | 20 (100) | 20 (100) | 20 (100) | 20 (100) | 120 (100) |
|
| ||||||||
|
| No | — | 1 (5) | 1 (5) | 2 (10) | — | 2 (10) | 6 (5) |
|
| Yes | 20 (100) | 19 (95) | 19 (95) | 18 (90) | 20 (100) | 18 (90) | 114 (95) |
|
| Total | 20 (100) | 20 (100) | 20 (100) | 20 (100) | 20 (100) | 20 (100) | 120 (100) |
|
| ||||||||
|
| No | 1 (10) | 1 (10) | 1 (5) | 3 (30) | 5 (50) | 1 (10) | 12 (20) |
|
| Yes | 9 (90) | 9 (90) | 9 (45) | 7 (70) | 5 (50) | 9 (90) | 48 (80) |
|
| Total | 10 (100) | 10 (100) | 10 (100) | 10 (100) | 10 (100) | 10 (100) | 60 (100) |
aLCA: lung cancer.
bCOPD: chronic obstructive pulmonary disease.
cDM: diabetes mellitus.
dCVD: cardiovascular disease.
eCKD: chronic kidney disease.
fCVA: cerebrovascular accident.
gNot available.
Proportion of source type by developer and disease.
| Source type | LCAa
| COPDb | DMc | CVDd | CKDe | CVAf | Total | |||||||
|
| ||||||||||||||
|
| Commercial | 2 (10) | 4 (33.3) | 6 (33.3) | 3 (21.4) | 3 (23.1) | 2 (14.3) | 20 (22) | ||||||
|
| Crowdsourced | 4 (20) | 0 | 0 | 0 | 2 (15.4) | 2 (14.3) | 8 (8.8) | ||||||
|
| Expert | 10 (50) | 6 (50) | 12 (66.7) | 9 (64.3) | 8 (61.5) | 10 (71.4) | 55 (60.4) | ||||||
|
| Not stated | 4 (20) | 2 (16.7) | 0 | 2 (14.3) | 0 | 0 | 8 (8.8) | ||||||
|
| Total | 20 (100) | 12 (100) | 18 (100) | 14 (100) | 13 (100) | 14 (100) | 91 (100) | ||||||
|
| ||||||||||||||
|
| Commercial | 4 (33.3) | 0 | 0 | 0 | 0 | 0 | 4 (16) | ||||||
|
| Crowdsourced | 5 (41.7) | 0 | 0 | 1 (50) | 1 (50) | 2 (50) | 9 (36) | ||||||
|
| Expert | 0 | 0 | 0 | 0 | 0 | 2 (50) | 2 (8) | ||||||
|
| Not stated | 3 (25) | 4 (100) | 1 (100) | 1 (50) | 1 (50) | 0 | 10 (40) | ||||||
|
| Total | 12 (100) | 4 (100) | 1 (100) | 2 (100) | 2 (100) | 4 (100) | 25 (100) | ||||||
|
| ||||||||||||||
|
| Commercial | 1 (5) | 10 (52.6) | 5 (26.3) | 4 (22.2) | 3 (15) | 1 (5.6) | 24 (21.1) | ||||||
|
| Crowdsourced | 4 (20) | 0 | 0 | 0 | 2 (10) | 0 | 6 (5.3) | ||||||
|
| Expert | 15 (75) | 9 (47.4) | 14 (73.7) | 14 (77.8) | 15 (75) | 17 (94.4) | 84 (73.7) | ||||||
|
| Total | 20 (100) | 19 (100) | 19 (100) | 18 (100) | 20 (100) | 18 (100) | 114 (100) | ||||||
|
| ||||||||||||||
|
| Commercial | 2 (22.2) | 5 (55.6) | 4 (44.4) | 1 (14.3) | 2 (40) | 1 (11.1) | 15 (31.3) | ||||||
|
| Expert | 7 (77.8) | 4 (44.4) | 5 (55.6) | 6 (85.7) | 3 (60) | 8 (88.9) | 33 (68.8) | ||||||
|
| Total | 9 (100) | 9 (100) | 9 (100) | 7 (100) | 5 (100) | 9 (100) | 48 (100) | ||||||
aLCA: lung cancer.
bCOPD: chronic obstructive pulmonary disease.
cDM: diabetes mellitus.
dCVD: cardiovascular disease.
eCKD: chronic kidney disease.
fCVA: cerebrovascular accident.